Correlation of pre-treatment 18F-FDG PET/CT metabolic parameters with short-term efficacy of radiotherapy for non-small cell lung cancer

被引:1
|
作者
Ma, C. [1 ]
Yin, Y. [2 ]
机构
[1] Shandong Canc Hosp & Inst, Radiat Oncol, Jinan, Shandong, Peoples R China
[2] Shandong Canc Hosp & Inst, Radiat Oncol Phys, Jinan, Shandong, Peoples R China
关键词
D O I
10.1016/S0959-8049(17)30668-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2057A
引用
收藏
页码:S183 / S183
页数:1
相关论文
共 50 条
  • [31] Detection of Recurrent Non-Small Cell Lung Cancer with Integrated 18F-FDG PET/CT
    Zhao, J.
    Gun, Y. H.
    Lu, S.
    Zuo, C. T.
    Lin, X. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S105 - S106
  • [32] The Role of Metabolic Parameters of Pre-treatment 18F-FDG PET/CT in Patients with Locally Advanced Cervical Cancer
    Wang, D.
    Hou, X.
    Hu, K.
    Zhang, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E497 - E498
  • [33] Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer
    Araz, Mine
    Soydal, Cigdem
    Ozkan, Elgin
    Sen, Elif
    Nak, Demet
    Kucuk, Ozlem N.
    Gonullu, Ugur
    Kir, K. Metin
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 66 (01): : 61 - 66
  • [34] 18F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer
    Gao, Ang
    Wang, Shijiang
    Fu, Zheng
    Sun, Xindong
    Yu, Jinming
    Meng, Xue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7561 - 7568
  • [35] Prognostic value of primary tumor SUVmax on pre-treatment 18F-FDG PET/CT imaging in patients with stage III non-small cell lung cancer
    Yilmaz, U.
    Batum, O.
    Koparal, H.
    Ozbilek, E.
    Kirakli, E.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (04): : 218 - 222
  • [36] New insight on the correlation of metabolic status on 18F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer
    Yang Wang
    Ning Zhao
    Zhanbo Wu
    Na Pan
    Xuejie Shen
    Ting Liu
    Feng Wei
    Jian You
    Wengui Xu
    Xiubao Ren
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1127 - 1136
  • [37] New insight on the correlation of metabolic status on 18F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer
    Wang, Yang
    Zhao, Ning
    Wu, Zhanbo
    Pan, Na
    Shen, Xuejie
    Liu, Ting
    Wei, Feng
    You, Jian
    Xu, Wengui
    Ren, Xiubao
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (05) : 1127 - 1136
  • [38] RELATIONSHIP BETWEEN 18F-FDG PET/CT METABOLIC PARAMETERS AND CLINICOPATHOLOGICAL FEATURES OF NON-SMALL CELL LUNG CANCER AND ITS PROGNOSTIC SIGNIFICANCE
    Su, Jian
    Meng, Haimei
    Tian, Hongying
    Li, Xiaodong
    Feng, Na
    Dong, Xi
    ACTA MEDICA MEDITERRANEA, 2022, 38 (04): : 2467 - 2474
  • [39] Automatic segmentation of tumour volume for non-small cell lung cancers with the 18F-FDG PET-CT for treatment by radiotherapy
    Boursot, C.
    Le Borgne, A.
    Barillot, I.
    Venel, Y.
    de Muret, A.
    Baulieu, J-L.
    Prunier-Aesch, C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (07): : 440 - 449
  • [40] Comparison of 18F-FDG PET/CT and MDCT for staging/restaging of non-small cell lung cancer
    Sobic-Saranovic, D.
    Petrusic, I.
    Artiko, V.
    Pavlovic, S.
    Subotic, D.
    Saranovic, D.
    Nagorni-Obradovic, L.
    Petrovic, N.
    Todorovic-Tirnanic, M.
    Odalovic, S.
    Grozdic-Milojevic, I.
    Stoiljkovic, M.
    Obradovic, V.
    NEOPLASMA, 2015, 62 (02) : 295 - 301